Official Publications Nanobiotix

Equities

Market Closed - Euronext Paris Other stock markets 11:35:02 2024-05-21 am EDT			Pre-market 02:00:53 am
6.51 ^EUR	-0.91%		6.615	+1.61%

May. 21	Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship	MT
May. 14	Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment	MT

Mixed general Shareholders meeting notice	May. 12	CO
Monthly statement on voting rights	Apr. 29	CO
Monthly statement on voting rights	Apr. 29	CO
Slide show results	Apr. 24	CO
Shareholder letter	Apr. 24	CO
Shareholder letter	Apr. 24	CO
Universal registration document	Apr. 24	CO
Annual results	Apr. 23	CO
Annual results	Apr. 23	CO
SEC Filing 20 F	Apr. 23	CO
Universal registration document	Apr. 23	CO
Combined general shareholders meeting	Apr. 21	CO
Monthly statement on voting rights	Mar. 30	CO
Monthly statement on voting rights	Mar. 30	CO
Monthly statement on voting rights	Jan. 30	CO
Monthly statement on voting rights	Jan. 30	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Nov. 29	CO
Monthly statement on voting rights	Nov. 29	CO
Threshold crossings	Nov. 28	CO
3rd quarter results	Nov. 12	CO
3rd quarter results	Nov. 12	CO
Threshold crossings	Nov. 07	CO
Monthly statement on voting rights	Nov. 07	CO